Visaris Vision® (Vision C, Vision U. Vision V, Vision X)— 510(k) K160620

Substantially Equivalent

Visaris D.O.O. Belgrade

FDA 510(k) clearance K160620 for Visaris Vision® (Vision C, Vision U. Vision V, Vision X), Substantially Equivalent on 2016-03-30. Applicant: Visaris D.O.O. Belgrade.

Clearance details

Applicant: Visaris D.O.O. Belgrade
Product code: Code KPR
Advisory panel: Radiology
Date received: 2016-03-04
Decision date: 2016-03-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Zemun, RS

Download summary PDF View on FDA.gov ↗

Adverse events under product code KPR

product code KPR

Other: 6
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.